1. Home
  2. KOSS vs ACET Comparison

KOSS vs ACET Comparison

Compare KOSS & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

N/A

Current Price

$3.16

Market Cap

32.8M

ML Signal

N/A

ACET

Adicet Bio Inc.

N/A

Current Price

$3.18

Market Cap

33.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOSS
ACET
Founded
1953
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
33.5M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
KOSS
ACET
Price
$3.16
$3.18
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $34.83
AVG Volume (30 Days)
21.8K
★ 195.4K
Earning Date
10-29-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.56
N/A
EPS
★ N/A
N/A
Revenue
★ $13,020,773.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.14
N/A
52 Week Low
$3.18
$0.46
52 Week High
$5.10
$9.97

Technical Indicators

Market Signals
Indicator
KOSS
ACET
Relative Strength Index (RSI) 27.89 20.08
Support Level N/A N/A
Resistance Level $4.14 $9.51
Average True Range (ATR) 0.18 0.31
MACD -0.05 -0.00
Stochastic Oscillator 4.20 5.53

Price Performance

Historical Comparison
KOSS
ACET

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: